The University serves Virginia, the nation, and the world by preparing responsible citizen-leaders; advancing, preserving, and disseminating knowledge; and providing world-class patient care.
All gifts of any kind help secure the University’s place as a premier institution of learning and make it possible for our students, faculty, and researchers to shape a brighter.
You can give to all 12 schools across Grounds. The possibilities are endless for supporting our students, faculty, and programs. Together, we will find the way forward.
You can join the growing number of alumni and friends who invest now in the University’s future by including UVA as a beneficiary of their wills, charitable trusts, and retirement plans. Gifts like these can offer you and your family significant tax benefits as well as greater financial flexibility in meeting your personal and philanthropic goals.
Through Honor the Future, the Campaign for the University of Virginia, we are building on our strong foundations to support the president’s vision: to become the best public university by 2030 and one of the very best in the world.
When we first featured Chloe Jarratt five years ago, she was a nine-year-old in elementary school and taking ballet classes after a clinical trial for type 1 diabetes. She was bright, curious, and positive. Where is she today?
Chloe has built inspirational resilience and strength. Her mother, Amanda Jarratt, gave us an update on her daughter that, given in her own words, also makes a powerful case for the crucial need for ongoing diabetes research.
Chloe is a sassy, healthy 14-year-old teenager. She maintains straight As in all of her classes while playing volleyball for the JV team for her school and participating in numerous other extracurricular activities. She is managing her type 1 diabetes independently and is looking forward to implementing the 780g system [recently approved insulin pump technology] in the next few weeks.
Her sister, Claire, was devastatingly diagnosed with type 1 diabetes on Christmas Day in 2021 and with Celiac on Christmas Eve in 2022. Chloe has been an amazing mentor to her younger sister and has helped her adjust to a life with type 1 diabetes as easily as it can be done. Utilizing the Trial Net system, we have had their younger brother, Ethan, tested for the antibodies associated with type 1 diabetes. For now, he does not show an indication of having them; however, we will test him every three years.
The LaunchPad for Diabetes Innovation Fund, created by businessman and investor Paul Manning, continues to support collaborative translational research projects at UVA that propose innovative and viable solutions to curing, treating, or diagnosing diabetes.
READ MORE: https://giving.virginia.edu/stories/launchpad-ignites-breakthrough
